Imaging CNS modulation of pain in humans

Physiology

Volumn 23, Issue 6, 2008, Pages 371-380

  Bingel, Ulrike ^a,b   Tracey, Irene ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BRAIN LEVEL; CENTRAL NERVOUS SYSTEM; CHRONIC DISEASE; HUMAN; METABOLISM; NERVE TRACT; NOCICEPTIVE RECEPTOR; PAIN; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW;

ANIMALS; BRAIN CHEMISTRY; CENTRAL NERVOUS SYSTEM; CHRONIC DISEASE; HUMANS; NEURAL PATHWAYS; NOCICEPTORS; PAIN;

EID: 57749100992     PISSN: 15489213     EISSN: 15489221     Source Type: Journal    
DOI: 10.1152/physiol.00024.2008     Document Type: Review

References (96)

1. Akil H, Watson SJ, Young E, Lewis ME, Khachaturian H, Walker JM. Endogenous opioids: biology and function. Annu Rev Neurosci 7: 223-255, 1984.
2. Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci 19: 484-494, 1999.
3. Apkarian AV, Bushnell MC, Treede RD, Zubieta JK. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain 9: 463-484, 2005.
4. Apkarian AV, Sosa Y, Sonty S, Levy RM, Harden RN, Parrish TB, Gitelman DR. Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci 24: 10410-10415, 2004.
5. Baliki MN, Chialvo DR, Geha PY, Levy RM, Harden RN, Parrish TB, Apkarian AV. Chronic pain and the emotional brain: specific brain activity associated with spontaneous fluctuations of intensity of chronic back pain. J Neurosci 26: 12165-12173, 2006.
6. Baliki MN, Geha PY, Apkarian AV. Spontaneous pain and brain activity in neuropathic pain: functional MRI and pharmacologic functional MRI studies. Curr Pain Headache Rep 11: 171-177, 2007.
7. Bantick SJ, Wise RG, Ploghaus A, Clare S, Smith SM, Tracey I. Imaging how attention modulates pain in humans using functional MRI. Brain 125: 310-319, 2002.
8. Becerra L, Harter K, Gonzalez RG, Borsook D. Functional magnetic resonance imaging measures of the effects of morphine on central nervous system circuitry in opioid-naive healthy volunteers. Anesth Analg 103: 208-216, 2006.
9. Benedetti F, Arduino C, Amanzio M. Somatotopic activation of opioid systems by target-directed expectations of analgesia. J Neurosci 19: 3639-3648, 1999.
10. Benedetti F, Arduino C, Costa S, Vighetti S, Tarenzi L, Rainero I, Asteggiano G. Loss of expectation-related mechanisms in Alzheimer's disease makes analgesic therapies less effective. Pain 121: 133-144, 2006.
11. Benedetti F, Mayberg HS, Wager TD, Stohler CS, Zubieta JK. Neurobiological mechanisms of the placebo effect. J Neurosci 25: 10390-10402, 2005.
12. Berman SM, Naliboff BD, Suyenobu B, Labus JS, Stains J, Ohning G, Kilpatrick L, Bueller JA, Ruby K, Jarcho J, Mayer EA. Reduced brainstem inhibition during anticipated pelvic visceral pain correlates with enhanced brain response to the visceral stimulus in women with irritable bowel syndrome. J Neurosci 28: 349-359, 2008.
13. Bingel U, Lorenz J, Schoell E, Weiller C, Buchel C. Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain 120: 8-15, 2006.
14. Bingel U, Schoell E, Herken W, Buchel C, May A. Habituation to painful stimulation involves the antinociceptive system. Pain 131: 21-30, 2007.
15. Brooks JC, Beckmann CF, Miller KL, Wise RG, Porro CA, Tracey I, Jenkinson M. Physiological noise modelling for spinal functional magnetic resonance imaging studies. Neuroimage 39: 680-692, 2008.
16. Coghill RC, McHaffie JG, Yen YF. Neural correlates of interindividual differences in the subjective experience of pain. Proc Natl Acad Sci USA 100: 8538-8542, 2003.
17. Demirci S, Savas S. The auditory event related potentials in episodic and chronic pain sufferers. Eur J Pain 6: 239-244, 2002.
18. Draganski B, Moser T, Lummel N, Ganssbauer S, Bogdahn U, Haas F, May A. Decrease of thalamic gray matter following limb amputation. Neuroimage 31: 951-957, 2006.
19. Dunckley P, Wise RG, Fairhurst M, Hobden P, Aziz Q, Chang L, Tracey I. A comparison of visceral and somatic pain processing in the human brainstem using functional magnetic resonance imaging. J Neurosci 25: 7333-7341, 2005.
20. Endo T, Spenger C, Westman E, Tominaga T, Olson L. Reorganization of sensory processing below the level of spinal cord injury as revealed by fMRI. Exp Neurol 209: 155-160, 2008.
21. Fairhurst M, Wiech K, Dunckley P, Tracey I. Anticipatory brainstem activity predicts neural processing of pain in humans. Pain 128: 101-110, 2007.
22. Fields HL. Pain modulation: expectation, opioid analgesia and virtual pain. Prog Brain Res 122: 245-253, 2000.
23. Fields HL, Bry J, Hentall I, Zorman G. The activity of neurons in the rostral medulla of the rat during withdrawal from noxious heat. J Neurosci 3: 2545-2552, 1983.
24. Flor H, Diers M, Birbaumer N. Peripheral and electrocortical responses to painful and non-painful stimulation in chronic pain patients, tension headache patients and healthy controls. Neurosci Lett 361: 147-150, 2004.
25. Gebhart GF. Descending modulation of pain. Neurosci Biobehav Rev 27: 729-737, 2004.
26. Geha PY, Baliki MN, Chialvo DR, Harden RN, Paice JA, Apkarian AV. Brain activity for spontaneous pain of postherpetic neuralgia and its modulation by lidocaine patch therapy. Pain 128: 88-100, 2007.
27. Grevert P, Albert LH, Goldstein A. Partial antagonism of placebo analgesia by naloxone. Pain 16: 129-143, 1983.
28. Hadjipavlou G, Dunckley P, Behrens TE, Tracey I. Determining anatomical connectivities between cortical and brainstem pain processing regions in humans: a diffusion tensor imaging study in healthy controls. Pain 123: 169-178, 2006.
29. Henderson LA, Gandevia SC, Macefield VG. Gender differences in brain activity evoked by muscle and cutaneous pain: a retrospective study of single-trial fMRI data. Neuroimage 39: 1867-1876, 2008.
30. Henriksen G, Willoch F. Imaging of opioid receptors in the central nervous system. Brain 131: 1171-1196, 2008.
31. Hoffman HG, Richards TL, Bills AR, Van Oostrom T, Magula J, Seibel EJ, Sharar SR. Using FMRI to study the neural correlates of virtual reality analgesia. CNS Spectr 11: 45-51, 2006.
32. Iannetti GD, Zambreanu L, Wise RG, Buchanan TJ, Huggins JP, Smart TS, Vennart W, Tracey I. Pharmacological modulation of pain-related brain activity during normal and central sensitization states in humans. Proc Natl Acad Sci USA 102: 18195-18200, 2005.
33. Kalisch R, Wiech K, Critchley HD, Seymour B, O'Doherty JP, Oakley DA, Allen P, Dolan RJ. Anxiety reduction through detachment: subjective, physiological, and neural effects. J Cogn Neurosci 17: 874-883, 2005.
34. Keltner JR, Furst A, Fan C, Redfern R, Inglis B, Fields HL. Isolating the modulatory effect of expectation on pain transmission: a functional magnetic resonance imaging study. J Neurosci 26: 4437-4443, 2006.
35. Kong J, Gollub RL, Rosman IS, Webb JM, Vangel MG, Kirsch I, Kaptchuk TJ. Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging. J Neurosci 26: 381-388, 2006.
36. Kosek E, Ordeberg G. Lack of pressure pain modulation by heterotopic noxious conditioning stimulation in patients with painful osteoarthritis before, but not following, surgical pain relief. Pain 88: 69-78, 2000.
37. Le Bars D, Dickenson AH, Besson JM. Diffuse noxious inhibitory controls (DNIC). I. Effects on dorsal horn convergent neurones in the rat. Pain 6: 283-304, 1979.
38. Le Bars D, Dickenson AH, Besson JM. Diffuse noxious inhibitory controls (DNIC). II. Lack of effect on non-convergent neurones, supraspinal involvement and theoretical implications. Pain 6: 305-327, 1979.
39. Levine JD, Gordon NC, Fields HL. The mechanism of placebo analgesia. Lancet 2: 654-657, 1978.
40. Lilja J, Endo T, Hofstetter C, Westman E, Young J, Olson L, Spenger C. Blood oxygenation level-dependent visualization of synaptic relay stations of sensory pathways along the neuroaxis in response to graded sensory stimulation of a limb. J Neurosci 26: 6330-6336, 2006.
41. Lorenz J, Minoshima S, Casey KL. Keeping pain out of mind: the role of the dorsolateral prefrontal cortex in pain modulation. Brain 126: 1079-1091, 2003.
42. Maarrawi J, Peyron R, Mertens P, Costes N, Magnin M, Sindou M, Laurent B, Garcia-Larrea L. Differential brain opioid receptor availability in central and peripheral neuropathic pain. Pain 127: 183-194, 2007.
43. MacIntosh BJ, Pattinson KT, Gallichan D, Ahmad I, Miller KL, Feinberg DA, Wise RG, Jezzard P. Measuring the effects of remifentanil on cerebral blood flow and arterial arrival time using 3D GRASE MRI with pulsed arterial spin labelling. J Cereb Blood Flow Metab 28: 1514-1522, 2008.
44. Mainero C, Zhang WT, Kumar A, Rosen BR, Sorensen AG. Mapping the spinal and supraspinal pathways of dynamic mechanical allodynia in the human trigeminal system using cardiac-gated fMRI. Neuroimage 35: 1201-1210, 2007.
45. Majcher K, Tomanek B, Jasinski A, Foniok T, Stroman PW, Tuor UI, Kirk D, Hess G. Simultaneous functional magnetic resonance imaging in the rat spinal cord and brain. Exp Neurol 197: 458-464, 2006.
46. Matre D, Casey KL, Knardahl S. Placebo-induced changes in spinal cord pain processing. J Neurosci 26: 559-563, 2006.
47. Meeus M, Nijs J, Van de Wauwer N, Toeback L, Truijen S. Diffuse noxious inhibitory control is delayed in chronic fatigue syndrome: an experimental study. Pain 139: 439-448, 2008.
48. Millan MJ. Descending control of pain. Prog Neurobiol 66: 355-474, 2002.
49. Mohr C, Binkofski F, Erdmann C, Buchel C, Helmchen C. The anterior cingulate cortex contains distinct areas dissociating external from self-administered painful stimulation: a parametric fMRI study. Pain 114: 347-357, 2005.
50. Moisset X, Bouhassira D. Brain imaging of neuropathic pain. Neuroimage 37, Suppl 1: S80-S88, 2007.
51. Morgan V, Pickens D, Gautam S, Kessler R, Mertz H. Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome. Gut 54: 601-607, 2005.
52. Oertel BG, Preibisch C, Wallenhorst T, Hummel T, Geisslinger G, Lanfermann H, Lotsch J. Differential opioid action on sensory and affective cerebral pain processing. Clin Pharmacol Ther 83: 577-588, 2008.
53. Pertwee RG. Cannabinoid receptors and pain. Prog Neurobiol 63: 569-611, 2001.
54. Peters ML, Schmidt AJ, Van den Hout MA. Chronic low back pain and the reaction to repeated acute pain stimulation. Pain 39: 69-76, 1989.
55. Petrovic P, Kalso E, Petersson KM, Ingvar M. Placebo and opioid analgesia: imaging a shared neuronal network. Science 295: 1737-1740, 2002.
56. Petrovic P, Petersson KM, Ghatan PH, Stone-Elander S, Ingvar M. Pain-related cerebral activation is altered by a distracting cognitive task. Pain 85: 19-30, 2000.
57. Pielsticker A, Haag G, Zaudig M, Lautenbacher S. Impairment of pain inhibition in chronic tension-type headache. Pain 118: 215-223, 2005.
58. Ploghaus A, Tracey I, Gati JS, Clare S, Menon RS, Matthews PM, Rawlins JN. Dissociating pain from its anticipation in the human brain. Science 284: 1979-1981, 1999.
59. Porreca F, Ossipov MH, Gebhart GF. Chronic pain and medullary descending facilitation. Trends Neurosci 25: 319-325, 2002.
60. Porro CA, Cettolo V, Francescato MP, Baraldi P. Functional activity mapping of the mesial hemispheric wall during anticipation of pain. Neuroimage 19: 1738-1747, 2003.
61. Price DD, Craggs J, Verne GN, Perlstein WM, Robinson ME. Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients. Pain 127: 63-72, 2007.
62. Proietti Cecchini A, Sandrini G, Fokin IV, Moglia A, Nappi G. Trigeminofacial reflexes in primary headaches. Cephalalgia 23, Suppl 1: 33-41, 2003.
63. Quevedo AS, Coghill RC. Attentional modulation of spatial integration of pain: evidence for dynamic spatial tuning. J Neurosci 27: 11635-11640, 2007.
64. Rainville P, Carrier B, Hofbauer RK, Bushnell MC, Duncan GH. Dissociation of sensory and affective dimensions of pain using hypnotic modulation. Pain 82: 159-171, 1999.
65. Salomons TV, Johnstone T, Backonja MM, Shackman AJ, Davidson RJ. Individual differences in the effects of perceived controllability on pain perception: critical role of the prefrontal cortex. J Cogn Neurosci 19: 993-1003, 2007.
66. Sarinopoulos I, Dixon GE, Short SJ, Davidson RJ, Nitschke JB. Brain mechanisms of expectation associated with insula and amygdala response to aversive taste: implications for placebo. Brain Behav Immun 20: 120-132, 2006.
67. Schmidt-Wilcke T, Leinisch E, Ganssbauer S, Draganski B, Bogdahn U, Altmeppen J, May A. Affective components and intensity of pain correlate with structural differences in gray matter in chronic back pain patients. Pain 125: 89-97, 2006.
68. Schmidt-Wilcke T, Leinisch E, Straube A, Kampfe N, Draganski B, Diener HC, Bogdahn U, May A. Gray matter decrease in patients with chronic tension type headache. Neurology 65: 1483-1486, 2005.
69. Schweinhardt P, Bountra C, Tracey I. Pharmacological FMRI in the development of new analgesic compounds. NMR Biomed 19: 702-711, 2006.
70. Schweinhardt P, Glynn C, Brooks J, McQuay H, Jack T, Chessell I, Bountra C, Tracey I. An fMRI study of cerebral processing of brush-evoked allodynia in neuropathic pain patients. Neuroimage 32: 256-265, 2006.
71. Schweinhardt P, Kalk N, Wartolowska K, Chessell I, Wordsworth P, Tracey I. Investigation into the neural correlates of emotional augmentation of clinical pain. Neuroimage 40: 759-766, 2008.
72. Sevcik MA, Jonas BM, Lindsay TH, Halvorson KG, Ghilardi JR, Kuskowski MA, Mukherjee P, Maggio JE, Mantyh PW. Endogenous opioids inhibit early-stage pancreatic pain in a mouse model of pancreatic cancer. Gastroenterology 131: 900-910, 2006.
73. Sherrington CS. The Integrative Action of the Nervous System. New Haven, CT: Yale Univ. Press, 1906.
74. Song GH, Venkatraman V, Ho KY, Chee MW, Yeoh KG, Wilder-Smith CH. Cortical effects of anticipation and endogenous modulation of visceral pain assessed by functional brain MRI in irritable bowel syndrome patients and healthy controls. Pain 126: 79-90, 2006.
75. Sprenger T, Berthele A, Platzer S, Boecker H, Tolle TR. What to learn from in vivo opioidergic brain imaging? Eur J Pain 9: 117-121, 2005.
76. Sprenger T, Valet M, Woltmann R, Zimmer C, Freynhagen R, Kochs EF, Tolle TR, Wagner KJ. Imaging pain modulation by subanesthetic S-(+)-ketamine. Anesth Analg 103: 729-737, 2006.
77. Stroman PW, Kornelsen J, Bergman A, Krause V, Ethans K, Malisza KL, Tomanek B. Noninvasive assessment of the injured human spinal cord by means of functional magnetic resonance imaging. Spinal Cord 42: 59-66, 2004.
78. Suzuki R, Rygh LJ, Dickenson AH. Bad news from the brain: descending 5-HT pathways that control spinal pain processing. Trends Pharmacol Sci 25: 613-617, 2004.
79. Tracey I, Dunckley P. Importance of anti- and pronociceptive mechanisms in human disease. Gut 53: 1553-1555, 2004.
80. Tracey I, Iannetti GD. Brainstem functional imaging in humans. Suppl Clin Neurophysiol 58: 52-67, 2006.
81. Tracey I, Mantyh PW. The cerebral signature for pain perception and its modulation. Neuron 55: 377-391, 2007.
82. 2 laser evoked potential study. Pain 105: 57-64, 2003.
83. Valet M, Sprenger T, Boecker H, Willoch F, Rummeny E, Conrad B, Erhard P, Tolle TR. Distraction modulates connectivity of the cingulofrontal cortex and the midbrain during pain: an fMRI analysis. Pain 109: 399-408, 2004.
84. Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ, Kosslyn SM, Rose RM, Cohen JD. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 303: 1162-1167, 2004.
85. Wager TD, Scott DJ, Zubieta JK. Placebo effects on human mu-opioid activity during pain. Proc Natl Acad Sci USA 104: 11056-11061, 2007.
86. Wiech K, Farias M, Kahane G, Shackel N, Tiede W, Tracey I. An fMRI study measuring analgesia enhanced by religion as a belief system. Pain 139: 467-476, 2008.
87. Wiech K, Kalisch R, Weiskopf N, Pleger B, Stephan KE, Dolan RJ. Anterolateral prefrontal cortex mediates the analgesic effect of expected and perceived control over pain. J Neurosci 26: 11501-11509, 2006.
88. Wiech K, Ploner M, Tracey I. Neurocognitive aspects of pain perception. Trends Cogn Sci 12: 306-313, 2008.
89. Wilder-Smith CH, Schindler D, Lovblad K, Redmond SM, Nirkko A. Brain functional magnetic resonance imaging of rectal pain and activation of endogenous inhibitory mechanisms in irritable bowel syndrome patient subgroups and healthy controls. Gut 53: 1595-1601, 2004.
90. Willer JC, Dehen H, Cambier J. Stress-induced analgesia in humans: endogenous opioids and naloxone-reversible depression of pain reflexes. Science 212: 689-691, 1981.
91. Xie CH, Kong KM, Guan JT, Chen YX, Wu RH. Functional MR imaging of the cervical spinal cord by use of 20 Hz functional electrical stimulation to median nerve. Conf Proc IEEE Eng Med Biol Soc 2007: 3392-3395, 2007.
92. Yarnitsky D, Crispel Y, Eisenberg E, Granovsky Y, Ben-Nun A, Sprecher E, Best LA, Granot M. Prediction of chronic post-operative pain: preoperative DNIC testing identifies patients at risk. Pain 138: 22-28, 2008.
93. Zambreanu L, Wise RG, Brooks JC, Iannetti GD, Tracey I. A role for the brainstem in central sensitisation in humans. Evidence from functional magnetic resonance imaging. Pain 114: 397-407, 2005.
94. Zubieta JK, Bueller JA, Jackson LR, Scott DJ, Xu Y, Koeppe RA, Nichols TE, Stohler CS. Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J Neurosci 25: 7754-7762, 2005.
95. Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, Koeppe RA, Stohler CS, Goldman D. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 299: 1240-1243, 2003.
96. Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, Meyer CR, Koeppe RA, Stohler CS. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 293: 311-315, 2001.